Triamterene (2,4,7-triamino -6 -phenylpteridine; SKF 8542) has been shown to produce a sodium diuresis with potassium retention in oedematous patients (Laragh et al., 1961; Donnelly et al., 1962) . This is not dependent upon a direct antagonism of aldosterone (Liddle, 1961) , for the effect is seen in the adrenalectomized subject not on salt-retaining steroids. Nevertheless, the drug is capable of reversing the sodium-retaining and potassium-wasting effects of administered 9a-fluorohydrocortisone in dogs (Wiebelhaus et al., 1961) and in man (Shaldon, 1961, unpublished observation), suggesting that its action is on the distal renal tubule at the site where sodium reabsorption is controlled by aldosterone. These unique properties have prompted its study in 10 cirrhotic patients with ascites. Such patients are known to be suffering from secondary hyperaldosteronism and are often resistant to diuretics such as thiazides or mercurials, and have in addition excessive potassium loss in the urine.
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The Investigation The 10 patients with portal cirrhosis and ascites gave no history of alcoholism or previous hepatitis (see Table) . All patients excreted less than 1 mEq of sodium per 24 hours in the urine on a daily sodium intake of 22 mEq. Before referral to the Royal Free Hospital they had required at least one paracentesis and were classified as " resistant" cases of ascites because of failure of previous diuretic therapy, which had included tfhiazides, mersalyl, and spironolactone. Strict dietary sodium restriction had not been practised. On admission the patients were put to bed and received daily 22 mEq of sodium and 60-90 mEq of dietary potassium without supplements; protein intake varied from 60 to 80 g. daily, but was constant in the individual patient; the fluid intake was measured but not restricted, and the patients were weighed daily. Urine collections were made over 24-hour periods, beginning at 8 a.m.
Biochemical methods used included sodium and potassium in serum and urine by flame photometry, chloride by potentiometric titration (Sanderson, 1952) , urea (Archer and Robb, 1925) , and creatinine in serum and urine (Hare, 1950 Table) . This reduction in creatinine clearance with elevation of the blood urea appeared during continuous daily diuretic therapy for longer than seven days with a combination of SKF 8542 and chlorothiazide. SKF 8542 in Combination with Spironolactone and Chlorothiazide (Fig. 4) (Crosley et al., 1961) . However, the drug acts in the absence of aldosterone, indicating a direct independent effect on the renal tubule. The potentiation by SKF 8542 of the sodium diuresis in four cirrhotic patients maintained on maximal doses of spironolactone supports the hypothesis that it inhibits sodium resorption independently of an aldosterone-blocking mechanism. The reduction in free water clearance suggests that its principal site of action is at the level of the distal tubule; a similar reduction in free water clearance has been observed with spironolactone (Shaldon, 1960) . The development of hyponatraemia and hypochloraemia is probably secondary to the reduction in free water clearance with consequent retention of water in excess of sodium and chloride. The previously reported potassium-retaining effects of SKF 8542 (Donnelly et al., 1962) were not clearly demonstrated in cirrhotic patients. The failure to achieve potassium conservation may have been partly due to the addition of chlorothiazide, although loss of potassium still occurred when SKF 8542 was used alone. This might be due to hyperaldosteronism which was not sufficiently counteracted by SKF 8542. The reduction in potassium loss when SKF 8542 was combined with chlorothiazide was similar to that seen when spironolactone and chlorothiazide were given together (Shaldon et al., 1960) , although with both combinations potassium supplements were still required for long-term use.
SKF 8542 definitely reduced the glomerular filtration rate, particularly when the drug was used with chlorothiazide. Elevation of the blood urea (Laragh et al., 1961 ; Donnelly et al., 1962) and reduction in glomerular filtration rates (Baba, personal communication, 1962) have also been observed when SKF 8542 was given alone to oedematous patients and normal subjects. The reduction in glomerular filtration rates in dogs following intravenous chlorothiazide has been attributed to a direct action of that drug in redistributing renal bloodflow within the kidney (Spencer, 1960) . We have, however, rarely noted a reduction in glomerular filtration rate when an intravenous load of a thiazide diuretic is given to cirrhotic patients (Shaldon et al., 1962 Distinctive features of the series were the high parity of the mothers and the fact that therapeutic abortion was never performed. This combination of circumstances provided an unusual opportunity to observe the effects of child-bearing on the course of the disease and at the same time to assess, albeit in a negative sense, the value of therapeutic abortion.
Immediate Results
The immediate results have been published (Drury et al., 1954; O'Driscoll et al., 1957 
